'Game-changing' HIV protection jab approved in England and Wales

The UK has approved a new injectable HIV prevention medication, a significant development in the fight against the virus. The shot, which offers long-lasting protection, is an alternative to the daily oral pre-exposure prophylaxis (PrEP) pills currently used. This "game-changing" injectable treatment, known as cabotegravir, is administered every two months or six times a year. It has been approved for use in England and Wales, providing a more convenient option for individuals at risk of contracting HIV. The approval of this injectable medication is expected to improve adherence and accessibility to HIV prevention, as it eliminates the need for daily pill-taking. This could be particularly beneficial for those who have difficulty remembering or accessing daily medication. The move is seen as a crucial step in the ongoing efforts to end the HIV epidemic, as the new injectable option offers a more discreet and efficient way to protect individuals from the virus.